Loading publications…
The last 5 uploaded publications
MYC activation impairs cell-intrinsic IFNγ signaling and confers resistance to anti-PD1/PD-L1 therapy in lung cancer
Pedro Blecua, Verónica Dávalos, Manel Esteller, Eva Pros, Paula Llabata, Manuel Torres-Diz, Anna Esteve‐Codina, Montse Sánchez‐Céspedes, Juan J. Alburquerque-Béjar, Pablo Navajas-Chocarro, Maria Saigí, Ana Ferrero-Andres, Juan M. Morillas, Andrea Vilarrubi, Antonio Gómez, José Luís Mate, Ana M Muñoz‐Mármol, Octavio A. Romero (2023). MYC activation impairs cell-intrinsic IFNγ signaling and confers resistance to anti-PD1/PD-L1 therapy in lung cancer. , 4(4), DOI: https://doi.org/10.1016/j.xcrm.2023.101006.
Article74 days agoData from Antitumor Activity of the Novel BTK Inhibitor TG-1701 Is Associated with Disruption of Ikaros Signaling in Patients with B-cell Non–Hodgkin Lymphoma
Marcelo Lima Ribeiro, Diana Reyes-Garau, Meritxell Vinyoles, Núria Profitós-Pelejà, Juliana C. Santos, Marc Armengol, Miranda Fernández-Serrano, Alícia Sedó Mor, Joan Josep Bech‐Serra, Pedro Blecua, Eva Musulén, Carolina de la Torre, Hari P. Miskin, Manel Esteller, Francesc Bosch, Pablo Menéndez, Emmanuel Normant, Gaël Roué (2024). Data from Antitumor Activity of the Novel BTK Inhibitor TG-1701 Is Associated with Disruption of Ikaros Signaling in Patients with B-cell Non–Hodgkin Lymphoma. , DOI: https://doi.org/10.1158/1078-0432.c.7556095.
Preprint74 days agoG protein-coupled receptor 183 mediates the sensitization of Burkitt lymphoma tumors to CD47 immune checkpoint blockade by anti-CD20/PI3Kδi dual therapy
Marcelo Lima Ribeiro, Núria Profitós-Pelejà, Juliana C. Santos, Pedro Blecua, Diana Reyes-Garau, Marc Armengol, Miranda Fernández-Serrano, Hari P. Miskin, Francesc Bosch, Manel Esteller, Emmanuel Normant, Gaël Roué (2023). G protein-coupled receptor 183 mediates the sensitization of Burkitt lymphoma tumors to CD47 immune checkpoint blockade by anti-CD20/PI3Kδi dual therapy. , 14, DOI: https://doi.org/10.3389/fimmu.2023.1130052.
Article74 days agoThe DNA methylation landscape of hematological malignancies: an update
Pedro Blecua, Laura Martinez‐Verbo, Manel Esteller (2020). The DNA methylation landscape of hematological malignancies: an update. , 14(8), DOI: https://doi.org/10.1002/1878-0261.12744.
Article74 days agoSupplementary Data from Antitumor Activity of the Novel BTK Inhibitor TG-1701 Is Associated with Disruption of Ikaros Signaling in Patients with B-cell Non–Hodgkin Lymphoma
Marcelo Lima Ribeiro, Diana Reyes-Garau, Meritxell Vinyoles, Núria Profitós-Pelejà, Juliana C. Santos, Marc Armengol, Miranda Fernández-Serrano, Alícia Sedó Mor, Joan Josep Bech‐Serra, Pedro Blecua, Eva Musulén, Carolina de la Torre, Hari P. Miskin, Manel Esteller, Francesc Bosch, Pablo Menéndez, Emmanuel Normant, Gaël Roué (2024). Supplementary Data from Antitumor Activity of the Novel BTK Inhibitor TG-1701 Is Associated with Disruption of Ikaros Signaling in Patients with B-cell Non–Hodgkin Lymphoma. , DOI: https://doi.org/10.1158/1078-0432.27904843.
Preprint74 days ago